FierceHealthcareFierceHealthITFierceHealthFinance   FiercePharmaFierceBiotechFierceSarbox
Syndicate content

Merck news from FierceHealthcare

Most Popular Merck story
Related Tags Vioxx   Food and Drug Administration (FDA)   lanier   painkiller
Tools

News

FL sues Merck over Vioxx marketing

October 1, 2008 — 1:00pm ET | By Anne Zieger
Florida's Attorney General has filed suit against Merck & Co., again, this time for allegedly deceptive marketing and promotion of joint pain drug Vioxx. The suit claims that Merck failed... Read more...

Drugmakers agree to six-month DTC delay

June 17, 2008 — 11:18am ET | By Anne Zieger
Under fire over direct-to-consumer ads, which some Congressional legislators contend are misleading to consumers, pharmaceutical companies have agreed to voluntarily wait six months after drugs are... Read more...

ALSO NOTED: FDA sending fewer warning letters;IL law would limit what hospitals can charge uninsured patients; and much more...

June 9, 2008 — 6:59am ET
> It looks like the FDA is sending out a lot fewer warning letters to potential violators of late. Officials say they're just changing emphasis, but critics suggest that th agency is slacking off.... Read more...

Merck agrees to $58M settlement on Vioxx ads

May 21, 2008 — 6:59am ET
Merck has agreed to a $58 million settlement with 29 states and the District of Columbia to settle allegations that it downplayed heart risks created by Vioxx in direct-to-consumer advertising. Under... Read more...

ALSO NOTED: Tenet reports $31M loss for quarter; FDA rules against broader Fentora use; and much more...

May 7, 2008 — 6:59am ET
> Tenet has reported a $31 million loss for the first quarter of this year. FierceHealthFinance... Read more...

ALSO NOTED: Group pushing for Medicare e-prescribing requirement; Merck cutting sales force; and much more...

May 6, 2008 — 6:59am ET
> If this coalition has its way, Medicare reforms will include a requirement that physicians use e-prescribing technology. Read more...

Studies show problems with four big-name drugs

April 29, 2008 — 6:59am ET
It looks like yet another set of popular drugs are facing allegations that they pose safety risks. Drugs named this week in unfavorable studies include Fosamax, which may create heart problems for... Read more...

Reports suggest that Merck downplayed Vioxx risks

April 16, 2008 — 6:59am ET
Another day, another report suggesting that a pharmaceutical company tried to bury data impugning the safety of one of its products. This time, a study has been published in The Journal of the... Read more...

Healthcare industry top spender on federal lobbying in '07

April 16, 2008 — 6:59am ET
It's good to get attention from federal legislators, but it's going to cost you. That's no mystery to some key healthcare groups, who collectively spent $445 million on federal lobbying during 2007,... Read more...

Congress says drugmakers held back Vytorin data

April 1, 2008 — 7:59am ET
Cholesterol drug Vytorin--and makers Merck and Schering-Plough--have been under fire for months since a study suggested that the expensive combo med works no better than much less costly Zocor.... Read more...
12345678next ›last »

Get more Merck coverage at:

FierceHealthIT
FierceHealthFinance